Company Profile
Lavender Ventures is a London-based venture capital firm dedicated to investing in and supporting UK-based pre-seed and seed-stage companies focused on female health and wellbeing, commonly known as femtech. The firm's core mission is to empower founders to build and scale businesses that address the unique health needs of women, a sector historically overlooked and under-invested. They aim to bridge the funding gap for women-led startups and bring innovative solutions to market.
The firm was founded in 2023 by Gail, who is deeply passionate about female health. Gail brings extensive operator experience from large corporate environments, startups, and scale-ups. Her background includes advisory roles with the NHS Femtech Accelerator and as a Board Advisor to Femella, a charity supporting young women. This blend of operational expertise and a wide network within the female health sector is leveraged to assist portfolio companies in their growth.
Lavender Ventures provides capital alongside practical help and mentorship to its portfolio companies. Their investment strategy focuses on early-stage ventures, specifically pre-seed and seed rounds, within the UK femtech landscape. Notable investments include companies such as Cyclana Bio, Unfabled, Chirpy, Punto Health, and OVUM, spanning various aspects of healthcare technology, personal products, and consumer non-durables.
Beyond funding, Lavender Ventures actively partners with founders to refine business and financial models, and implement agile product development methodologies like Scrum. This hands-on approach aims to ensure efficient progress and successful outcomes for the innovative solutions being developed in the women's health space.
News & Signals (0)
No linked news activity found for this company.